<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02042755</url>
  </required_header>
  <id_info>
    <org_study_id>POD AY 26P FineVision</org_study_id>
    <nct_id>NCT02042755</nct_id>
  </id_info>
  <brief_title>Pilot Study With a Diffractive Trifocal IOL (POD AY 26P FineVision)</brief_title>
  <official_title>Pilot Study With a Diffractive Trifocal IOL (POD AY 26P FineVision)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Physiol</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Physiol</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The principal objective of the study is to determine the visual acuity at far, intermediate
      and near distances tested with optotypes at different distances from the eyes and tested with
      defocus addition lenses of patients implanted bilaterally with the POD 26P AY FineVision.

      Secondary objective will be to test the glare and contrast sensitivity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a pilot study. As such it will recruit a limited number of patients : 20.
      Patients recruited will suffer from cataract, have no comorbidity, expressed the desire for
      spectacle independence and have realistic expectations.

      Descriptive statistics will be used to determine the visual acuities at any distance. The
      occurence of glare and the determination of the contrast sensitivity will also be determined.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Actual">May 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Visual acuity</measure>
    <time_frame>3 months</time_frame>
    <description>At far, near and intermediate distance.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Contrast sensitivity</measure>
    <time_frame>3 months</time_frame>
    <description>Assessment of the contrast sensitivity: determination of the visual acuity with low-contrast chart (Pelli Robson standard sight-chart ).</description>
  </secondary_outcome>
  <enrollment type="Actual">19</enrollment>
  <condition>Bilateral Cataract</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>trifocal intraocular lens</intervention_name>
    <description>Standard cataract surgery</description>
    <other_name>Physiol POD 26P AY FineVision</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Cataract patients wishing high spectacle independance after the surgery
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  - Age-related cataract

          -  Preoperative Corneal astigmatism &lt; 0.75 D

          -  Age 21 and older

          -  Visual Acuity &gt; 0.05

          -  Normal findings in the medical history and physical examination unless the
             investigator considers an abnormality to be clinically irrelevant.

          -  Patient willing multifocal implantation and with realistic expectations.

        Exclusion Criteria:

          -  Relevant other ophthalmic diseases such as pseudoexfoliation syndrome, floppy iris
             syndrome, corneal pathologies, retinal pathology (diabetic maculopathy, myopic
             maculopathy, age related macular degeneration...)

          -  Previous ocular surgery or trauma.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Irit Bahar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rabin Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rabin Medical Center 49Th Jabotinsky Street</name>
      <address>
        <city>Petach Tikva</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 20, 2013</study_first_submitted>
  <study_first_submitted_qc>January 20, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 23, 2014</study_first_posted>
  <last_update_submitted>January 18, 2017</last_update_submitted>
  <last_update_submitted_qc>January 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cataract</keyword>
  <keyword>IOL</keyword>
  <keyword>trifocal</keyword>
  <keyword>FineVision</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

